Human retinal pigment epithelium cells as functional models for the RPE in vivo

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8614-8620

  Ablonczy, Zsolt ^a   Dahrouj, Mohammad ^a   Tang, Peter H ^a   Liu, Yueying ^a   Sambamurti, Kumar ^a   Marmorstein, Alan D ^b   Crosson, Craig E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR; RETINOID; VASCULOTROPIN; ANTINEOPLASTIC AGENT; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; RETINAL; RETINOIC ACID; SERINE PROTEINASE INHIBITOR; VASCULOTROPIN A; VEGF LIKE PROTEIN, ORF VIRUS; VEGF-LIKE PROTEIN, ORF VIRUS; VEGFA PROTEIN, HUMAN; VIRUS PROTEIN;

ARTICLE; BIOLOGICAL MODEL; CELL MEMBRANE PERMEABILITY; CELL SECRETION; CELL STRUCTURE; CELLULAR PARAMETERS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MONOLAYER CULTURE; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIGHT JUNCTION; TRANSEPITHELIAL RESISTANCE; BIOASSAY; CELL LINE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; SECRETION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CELL LINE; EPITHELIAL CELLS; EYE PROTEINS; HUMANS; MEMBRANE POTENTIALS; NERVE GROWTH FACTORS; RETINAL PIGMENT EPITHELIUM; RETINALDEHYDE; SERPINS; TIGHT JUNCTIONS; TRETINOIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIRAL PROTEINS;

EID: 84855388508     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-8021     Document Type: Article

References (28)

1. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol. 1999;97:217-228.
2. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev. 2004; 84:869-901.
3. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:C1213-C1228.
4. Marmor MF. Mechanisms of fluid accumulation in retinal edema. Doc Ophthalmol. 1999;97:239-249.
5. Marneros AG, Fan J, Yokoyama Y, et al. Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol. 2005;167:1451-1459.
6. Ciulla TA, Rosenfeld PJ. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:166-174.
7. Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res. 1995;27:48-52.
8. Lara-Castillo N, Zandi S, Nakao S, et al. Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization. Am J Pathol. 2009;175:2343-2350.
9. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999;14:223-232.
10. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res. 1995;14: 1015-1020.
11. Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, Sambamurti K. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem. 2009;284: 30177-30186.
12. Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun. 2003;303: 962-967.
13. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
14. Ablonczy Z, Crosson CE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007;85:762-771.
15. Hartnett ME, Lappas A, Darland D, McColm JR, Lovejoy S, D'Amore PA. Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. Exp Eye Res. 2003;77:593-599.
16. Jin M, Barron E, He S, Ryan SJ, Hinton DR. Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. Invest Ophthalmol Vis Sci. 2002;43:2782-2790.
17. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol. 1999;155:421-428.
18. Hu J, Bok D. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol Vis. 2001;7:14-19.
19. Maminishkis A, Chen S, Jalickee S, et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci. 2006;47:3612-3624.
20. Peng S, Adelman RA, Rizzolo LJ. Minimal effects of VEGF and anti-VEGF drugs on the permeability or selectivity of RPE tight junctions. Invest Ophthalmol Vis Sci. 2010;51:3216-3225.
21. Ghassemifar R, Lai CM, Rakoczy PE. VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha-and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res. 2006;323:117-125.
22. Miyamoto N, de Kozak Y, Jeanny JC, et al. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy. Diabetologia. 2007;50:461-470.
23. Tombran-Tink J, Shivaram SM, Chader GJ, Johnson LV, Bok D. Expression, secretion, and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity. J Neurosci. 1995;15:4992-5003.
24. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epitheliumderived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006;82:99-110.
25. Ma J, Zhang J, Othersen KL, et al. Expression, purification, and MALDI analysis of RPE65. Invest Ophthalmol Vis Sci. 2001;42: 1429-1435.
26. Groenendijk GW, De-Grip WJ, Daemen FJ. Quantitative determination of retinals with complete retention of their geometric configuration. Biochim Biophys Acta. 1980;617:430-438.
27. Gamm DM, Melvan JN, Shearer RL, et al. A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2008;49:788-799.
28. Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes. 2001;50:2641-2645.